Tag: REMS
Biologics: The New Antitrust Frontier
Posted by Social Science Research Network
Biologics: The New Antitrust Frontier
By Michael A. Carrier & Carl J. Minniti III (Rutgers University)
Abstract: The pharmaceutical...
Sharing, Samples, and Generics: An Antitrust Framework
Posted by Social Science Research Network
Sharing, Samples, and Generics: An Antitrust Framework
By Michael A. Carrier (Rutgers Law School)
Abstract: Rising drug prices are in...
Refusal to Deal Under FDA Imposed Risk Evaluation and Mitigation Strategies...
This article is part of a Chronicle. See more from this Chronicle
Robert Maness, Brian Segers, Apr 29, 2014
The Federal Trade Commission, as part of...
When Does Sharing Make Sense?: Antitrust & Risk Evaluation and Mitigation...
This article is part of a Chronicle. See more from this Chronicle
Jan Rybnicek, Apr 29, 2014
There exists a new front in the battle to...
